94 related articles for article (PubMed ID: 23343096)
1. Association of human papillomavirus type 16 long control region mutation and cervical cancer.
Pientong C; Wongwarissara P; Ekalaksananan T; Swangphon P; Kleebkaow P; Kongyingyoes B; Siriaunkgul S; Tungsinmunkong K; Suthipintawong C
Virol J; 2013 Jan; 10():30. PubMed ID: 23343096
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.
Shang Q; Wang Y; Fang Y; Wei L; Chen S; Sun Y; Li B; Zhang F; Gu H
J Clin Microbiol; 2011 Jul; 49(7):2656-63. PubMed ID: 21593270
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China.
Fang L; Lin X; Yang Y; Song Z; Ding X; Tan L; Gao P
Virol J; 2020 Jul; 17(1):106. PubMed ID: 32677948
[TBL] [Abstract][Full Text] [Related]
4. The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women.
Bel Haj Rhouma R; Ardhaoui M; Othman H; Ben Jemia Z; Zine El Abidine A; Fehri E; Ouerheni K; Laassili T; Tounsi H; Guizani I; Boubaker MS; Ennaifer E
Infect Genet Evol; 2023 Dec; 116():105536. PubMed ID: 38048896
[TBL] [Abstract][Full Text] [Related]
5. Characterization and whole genome analysis of human papillomavirus type 16 e1-1374^63nt variants.
Sabol I; Matovina M; Si-Mohamed A; Grce M
PLoS One; 2012; 7(7):e41045. PubMed ID: 22911739
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type distribution and HPV16 intratype diversity in southern Brazil in women with and without cervical lesions.
de Oliveira GR; Vieira VC; Ávila EC; Finger-Jardim F; Caldeira TD; Gatti FA; Gonçalves CV; Oliveira SG; da Hora VP; Soares MA; de Martinez AM
Mem Inst Oswaldo Cruz; 2017 Jul; 112(7):492-498. PubMed ID: 28591310
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
Clifford GM; Tenet V; Georges D; Alemany L; Pavón MA; Chen Z; Yeager M; Cullen M; Boland JF; Bass S; Steinberg M; Raine-Bennett T; Lorey T; Wentzensen N; Walker J; Zuna R; Schiffman M; Mirabello L
Papillomavirus Res; 2019 Jun; 7():67-74. PubMed ID: 30738204
[TBL] [Abstract][Full Text] [Related]
8. Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population.
Hang D; Yin Y; Han J; Jiang J; Ma H; Xie S; Feng X; Zhang K; Hu Z; Shen H; Clifford GM; Dai M; Li N
Virology; 2016 Jan; 488():156-61. PubMed ID: 26650690
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Cervical Cancer Caused by the Human Papillomavirus 18 and Its Genetic Variations in Vietnamese Women.
Hung TM; Son HX; Bang LVN; Van Duyet L
Infect Genet Evol; 2024 Jan; 117():105546. PubMed ID: 38176603
[TBL] [Abstract][Full Text] [Related]
10. The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
Lou H; Boland JF; Torres-Gonzalez E; Albanez A; Zhou W; Steinberg MK; Diaw L; Mitchell J; Roberson D; Cullen M; Garland L; Bass S; Burk RD; Yeager M; Wentzensen N; Schiffman M; Freites EA; Gharzouzi E; Mirabello L; Dean M
Cancer Res; 2020 Sep; 80(18):3803-3809. PubMed ID: 32631904
[TBL] [Abstract][Full Text] [Related]
11. HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.
Gameiro SF; Salnikov MY; Zeng PYF; Barrett JW; Nichols AC; Mymryk JS
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140652
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
Bønløkke S; Steiniche T; Sorensen BS; Nyvang GB; Lindegaard JC; Blaakær J; Bertelsen J; Fuglsang K; Strube ML; Lenz S; Stougaard M
Mol Oncol; 2024 May; 18(5):1231-1244. PubMed ID: 37853962
[TBL] [Abstract][Full Text] [Related]
13. Changes in intrahost genetic diversity according to lesion severity in longitudinal HPV16 samples.
Costanzi JM; Stosic MS; Løvestad AH; Ambur OH; Rounge TB; Christiansen IK
J Med Virol; 2024 May; 96(5):e29641. PubMed ID: 38708811
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16.
Minhas S; Kashif M; Nisar H; Idrees M; Ansari F
Exp Biol Med (Maywood); 2023 Dec; 248(23):2332-2340. PubMed ID: 38196081
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance.
Zhu B; Xiao Y; Yeager M; Clifford G; Wentzensen N; Cullen M; Boland JF; Bass S; Steinberg MK; Raine-Bennett T; Lee D; Burk RD; Pinheiro M; Song L; Dean M; Nelson CW; Burdett L; Yu K; Roberson D; Lorey T; Franceschi S; Castle PE; Walker J; Zuna R; Schiffman M; Mirabello L
Nat Commun; 2020 Feb; 11(1):886. PubMed ID: 32060290
[TBL] [Abstract][Full Text] [Related]
16. Decoding the Genetic and Structural Features of HPV16 E5 Oncogene in Cervical Cancer Isolates from Pakistan: A Pilot Study.
Ilahi NE; Siddique N; Rashid MI; Noreen M; Murad S
Iran Biomed J; 2023 Aug; 27(6):388-96. PubMed ID: 38158635
[TBL] [Abstract][Full Text] [Related]
17. A unified view of low complexity regions (LCRs) across species.
Lee B; Jaberi-Lashkari N; Calo E
Elife; 2022 Sep; 11():. PubMed ID: 36098382
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations of human papillomavirus type 16: implications for cervical carcinogenesis.
Kukimoto I; Muramatsu M
Jpn J Infect Dis; 2015; 68(3):169-75. PubMed ID: 25766614
[TBL] [Abstract][Full Text] [Related]
19. The possible impact of novel mutations in human papillomavirus 52 on the infection characteristics.
Gong Y; Wang Y; Zhou Q; Qu W; Chen F; Wang Y; Mo J; Zhang H; Lin L; Bi T; Wang X; Gu J; Sui L; Li Y
Microb Genom; 2023 Apr; 9(4):. PubMed ID: 37103992
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
